The iron letter - An update on the treatment of iron deficiency anemia;Eisenbrief - Aktuelle empfehlungen zur therapie der eisenmangelanämie

Praxis

Volumn 95, Issue 10, 2006, Pages 357-364

  Schaefer, R M ^a   Huch, R ^b,c   Krafft, A ^b   Beer, K ^c   Beglinger, Ch ^c   Beris, P ^c   Breymann, Ch ^c   Furrer, J ^c   Hess, O ^c   Kirchner, V ^c   Leyvraz, S ^c   Litschgi, M ^c   Ozsahin, H ^c   Ozsahin, M ^c   Ruedin, P ^c   Spahn, D R ^c   Walpoth, B ^c   Wuthrich R ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NONE

Author keywords

Epoetin alfa; Gastroenterology; Iron deficiency anemia; Iron saccharate; Iron substitution; Pregnancy; Renal anemia

Indexed keywords

EID: 80051665144     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.95.10.357     Document Type: Review

References (20)

1. Hercberg S, Preziosi P, Galan P: Iron deficiency in Europe. Public Health Nutr 2001;4(2B):537-545. (Pubitemid 32524575)
2. Kaltwasser JP, Gottschalk R: Erythropoietin and iron. Kidney Int Suppl 1999;69:S49-S56. (Pubitemid 29113583)
3. Schaefer RM, Schaefer L: Hypochromic red blood cells and reticulocytes. Kidney Int Suppl 1999;69:S44-S48. (Pubitemid 29113582)
4. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J: A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001;60(6):2406-2411. (Pubitemid 33070486)
5. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 1999;14 Suppl 5:1-50.
6. Kosch M, Schaefer RM, Bahner U: Substitution mit Mineralstoffen und Spurenelementen. Internist (Berl) 2002;43(10):1299-1307.
7. Kosch M, Schaefer RM: Indikation und praktische Durchführung der parenteralen Eisentherapie. Wien Klin Wochenschr 2003;115(11):380-384. (Pubitemid 36827698)
8. Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM: A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant 2001;16(6):1239-1244. (Pubitemid 32547381)
9. Chandler G, Harchowal J, Macdougall IC: Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001;38(5):988-991. (Pubitemid 33022176)
10. Schaefer RM, Schaefer L: Management of iron substitution during rhEPO therapy in chronic renal failure patients. Erythropoiesis 1992;3:71-75.
11. Dejaco C, Gasche C: Anämie bei chronisch entzündlichen Darmerkrankungen: Ein oft unterschätztes Problem. Dtsch Med Wochenschr 2002;127(15):805-808. (Pubitemid 34311296)
12. Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W; Austrian Inflammatory Bowel Diseases Study Group: Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001;96(8):2382-2387. (Pubitemid 32769199)
13. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H: Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997;126(10):782-787. (Pubitemid 27209644)
14. Milman N, Bergholt T, Byg KE, Eriksen L, Graudal N: Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand 1999;78(9):749-757. (Pubitemid 29486047)
15. Breymann C, Visca E, Huch R, Huch A: Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 2001;184(4):662-667. (Pubitemid 32234981)
16. Perewusnyk G, Huch R, Huch A, Breymann C: Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr 2002;88(1):3-10. (Pubitemid 34752309)
17. Krafft A, Breymann C, Quack K, Huch R: Severe anemia in the puerperium: selective use of recombinant human erythropoietin (rhEPO) and iron sucrose in the avoidance of blood transfusion. Transfusion Alternatives in Transfusion Medicine 2002;4 Suppl 2:75-76.
18. Fishbane S: Safety in iron management. Am J Kidney Dis 2003;41(5 Suppl):18-26.
19. FDA: Adverse Event Reporting System (AERS), Freedom of Information (FOI) Report, From:01-Nov-1997 to: present.
20. Macdougall I, Bailie G, Richardson D et al.: World-wide safety profile of iron sucrose injection (Venofer): Analysis of 1,004,477 patients from 1992 to 2001. Presented at the ASN World Congress of Nephrology, Oct. 13-17, 2001, San Francisco, CA.